CN106511596A - Traditional Chinese medicine for treating coronary heart disease - Google Patents
Traditional Chinese medicine for treating coronary heart disease Download PDFInfo
- Publication number
- CN106511596A CN106511596A CN201611171198.5A CN201611171198A CN106511596A CN 106511596 A CN106511596 A CN 106511596A CN 201611171198 A CN201611171198 A CN 201611171198A CN 106511596 A CN106511596 A CN 106511596A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- heart disease
- coronary heart
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates a traditional Chinese medicine for treating coronary heart disease. The traditional Chinese medicine is prepared from 2-3 parts of radix tinosporae, 2-3 parts of cornua cervi pantotrichum, 3-5 parts of hawksbill turtle shell, 15-20 parts of dried radix rehmanniae, 12-18 parts of semen juglandis, 10-20 parts of seed of Chinese dodder, 10-20 parts of semen litchi, 10-20 parts of rhodiola rosea, 10-20 parts of radix polygoni multiflori preparata, 10-20 parts of white atractylodes rhizome, 10-20 parts of achymthes bidentata blume, 10-20 parts of ginkgo nuts, 10-20 parts of mulberry, 12-25 parts of achymthes bidentata blume, 12-25 parts of fructus ziziphi jujubae, 15-20 parts of flos chrysanthemi,6-9 parts of flos carthami, 12-17 parts of radix morindae officinalis, 10-20 parts of fructus rubi and 10-15 parts of liquorice root. The traditional Chinese medicine provided by the invention is prepared on the basis of a secret prescription handed down from ancestors and the summary of clinical experiences for years through repeated experiments; therefore, the medicine has a unique curative effect on such symptoms as myocardial ischemia, angina, uneasiness, oppression in chest, insomnia and dreaminess, cardio-cerebrovascular sclerosis and the like caused by the intractable coronary heart disease; the medicine is scientific in compatibility and rapid to take a curative effect; and the medicine has functions of nourishing liver and kidney, calming heart and tranquilizing, promoting blood circulation and removing stasis, promoting circulation of qi and alleviating pain, reinforcing vital essence and strengthening primordial qi, and balancing yin and yang. The medicine, on the myocardial ischemia and the angina caused by the coronary heart disease, has the advantages of being rapid to take effects, short in treatment course, high in cure rate and low in expense.
Description
Technical field
The present invention relates to a kind of Chinese medicine, more particularly to it is a kind of with Chinese herbal medicine as treatment coronary heart disease prepared by raw material in
Medicine.
Background technology
Coronary heart disease, also known as ischemic heart disease, is to cause hemadostewnosis or obstruction due to coronary atherosclerosis, is occurred
Coronary circulation obstacle, causes a kind of heart disease of myocardial ischemia, anoxic or necrosis.At present, three generally acknowledged in the world big treatment ways
Footpath includes drug therapy, PCI and surgical intervention.Due to the most drug curing myocardial ischemia effect serious to pathology
It is limited, and PCI and surgical intervention that other positions of coronary artery of patient can not be prevented to occur is narrow, so these three
Treatment can not effect a radical cure coronary heart disease.Traditional Chinese medicine thinks that coronary heart disease belongs to the disease of heart and the train of thought of nutritional cardio, its pathogenic factor
Be it is many, and with whole body change have close relationship.Main aspect is due to worn with age, healthy tendency virtual loss, internal organs
Function damage, yin and yang qi and blood disorder add the impact of the factors such as inernal injuries caused by seven emotions, eating and drinking without temperance, cold stimulation, work and rest mistake degree, lead
Qi depression to blood stasis is caused, hypofunction of YANG QI in chest, the turbid interior life of phlegm make heart vessel blockage stasis and cause a disease.Wherein, zang-fu differentiation qi and blood functional disturbance, human body
The balance of yin and yang in equilibrium is destroyed, and is the immanent cause of morbidity.Internal cause is the basis of morbidity, and external cause is the condition of morbidity.Controlling
Treated with decoction of medicinal ingredients frequently with tonifying Qi and blood, nourishment for vitality etc rule in terms for the treatment of, take inconvenience, curative effect is also imprecise.
The content of the invention
The purpose of the present invention is to overcome prior art not enough, and a kind of curative effect of offer is fast, expense is low, having no toxic side effect can root
Control the Chinese medicine of coronary heart disease.
To realize the purpose of the present invention, now depending on following technical scheme.The medicine is by following weight
Raw material is made:
Tinosporae 2-3 parts, pilose antler 2-3 parts, hawksbill turtle 3-5 parts, dried rhizome of rehmannia 15-20 parts, walnut kernel 12-18 parts, seed of Chinese dodder 10-20 parts,
Semen litchi 10-20 parts, rhodiola root 10-20 parts, RADIX POLYGONI MULTIFLORI PREPARATA 10-20 parts, bighead atractylodes rhizome 10-20 parts, radix achyranthis bidentatae 10-20 parts, ginkgo nut 10-
20 parts, mulberry fruit 10-20 parts, radix achyranthis bidentatae 12-25 parts, date 12-25, chrysanthemum 15-20 parts, safflower 6-9 parts, Morinda officinalis 12-17 parts,
Raspberry 10-20 parts, 10 15 parts of Radix Glycyrrhizae.
Inventors believe that, this disease is to cause human body myocardial ischemia due to liver-kidney deficiency, makes heart working be subject to different journeys
The impact of degree, thus produces a series of ischemic sex expression, such as uncomfortable in chest, the dizzy, symptom such as feel suffocated.Therefore treat this disease to adopt
With nourishing liver and kidney, antitoxic heart-soothing and sedative, method balanced human's vital organs of the human body equilibrium between yin and yang promoting blood circulation and removing blood stasis, improve myocardial ischemia symptom,
Can be only achieved the radical cure effect of recurrence for the treatment of both principal and secondary aspect of disease, be difficult.
Fang Xie:
Tinosporae:Nature and flavor bitter cold, has clearing heat and detoxicating, profit pharynx, the effect of pain relieving.
Pilose antler:Tonifying kidney and strengthening yang, production of sperm benefit blood, mends marrow strong bone ".Entirely
Hawksbill turtle:It is sweet, it is cold in nature.There iss tranquilizing mind, calming the liver to stop the wind.
The dried rhizome of rehmannia:Clearing heat and cooling blood, yin-nourishing are promoted the production of body fluid.
Walnut kernel:Kidney tonifying warm lung, relaxes bowel.
The seed of Chinese dodder:The effect of with nourishing liver and kidney, astringent sperm contracting urine, antiabortive, improving eyesight, antidiarrheal.
Semen litchi:Promoting the circulation of qi dissipating bind, cold-dispelling pain-relieving.
Rhodiola root:There are tonifying Qi clearing lung-heat, intelligence development nourishing heart, controlling of bleeding with astringents, eliminating stasis to subdue swelling.
RADIX POLYGONI MULTIFLORI PREPARATA:Turbid lipid-loweringing is changed in filling liver kidney, benefiting essence-blood, black beard and hair, strengthening the bones and muscles.
The bighead atractylodes rhizome:Strengthening the spleen and replenishing qi, eliminate dampness and have diuretic effect, hidroschesis are antiabortive.
Radix achyranthis bidentatae:Promoting blood circulation to remove blood stasis, clearing damp diuresis are clearing heat and detoxicating.
Ginkgo nut:Astringe the lung gas, relieving asthma and cough, check with turbidity, reduce function just.
Mulberry fruit:The effects such as with liver-kidney tonifying, fluid dryness, UFA eyesight.
Date:With nourishment for vitality, the effect of enriching blood.
Chrysanthemum:There are dispelling wind, the work(of flat liver, smell it, have auxiliary therapeutic action to flu, headache.
Safflower:Invigorate blood circulation, stasis eliminatings pain relieving.
Morinda officinalis:Cure mainly impotence and seminal emission, uterus cold infertile, irregular menstruation, few abdomen crymodynia, arthralgia due to wind-dampness, muscles and bones impotence.
Raspberry:With supplementing the kidney to control the nocturnal contracting urine, the effect of nourishing the liver to improve visual acuity.It is usually used in emission and spermatorrhea, enuresis frequent micturition, impotence morning
Let out, mesh is secretly dim-sighted.
Radix Glycyrrhizae:Indication is clearing heat and detoxicating, expelling phlegm and arresting coughing, gastral cavity abdomen etc..
The Chinese medicine of the treatment coronary heart disease of the present invention, preparation method are as follows:
(1), each medicinal material is screened by prescription, weigh it is standby;
(2) it is, last, 150 mesh sieves excessively by the pulverizing medicinal materials for weighing, is well mixed;
(3), by mixed powder water general for ball, medicine as of the present invention.
The present invention be inventor on the basis of secret prescription handed down in the family from generation to generation, with reference to the summary of oneself clinical experience for many years, through repeatedly
Experiment and obtain, therefore the medicine intractable coronary heart disease is caused myocardial ischemia, angina pectoris, nervous, uncomfortable in chest, insomnia and dreamful sleep, heart and brain
The diseases such as vascular sclerosis have the curative effect of uniqueness, and the medicine compatibility science, curative effect are rapid, with nourishing liver and kidney, antitoxic heart-soothing and sedative, promoting blood circulationization
The stasis of blood, promoting qi circulation and relieving pain, reinvigoration, effect of Yin Yang balancing.The myocardial ischemia that causes to coronary heart disease, angina pectoris and having is shown in
The advantage that effect is fast, short treating period, cure rate are high, expense is little.
Specific embodiment
Raw material is weighed in following ratio:
Tinosporae 2-3 parts, pilose antler 2-3 parts, hawksbill turtle 3-5 parts, dried rhizome of rehmannia 15-20 parts, walnut kernel 12-18 parts, seed of Chinese dodder 10-20 parts,
Semen litchi 10-20 parts, rhodiola root 10-20 parts, RADIX POLYGONI MULTIFLORI PREPARATA 10-20 parts, bighead atractylodes rhizome 10-20 parts, radix achyranthis bidentatae 10-20 parts, ginkgo nut 10-
20 parts, mulberry fruit 10-20 parts, radix achyranthis bidentatae 12-25 parts, date 12-25, chrysanthemum 15-20 parts, safflower 6-9 parts, Morinda officinalis 12-17 parts,
Raspberry 10-20 parts, 10 15 parts of Radix Glycyrrhizae.
The Chinese medicine of the treatment coronary heart disease of the present invention, preparation method are as follows:
(1), each medicinal material is screened by prescription, weigh it is standby;
(2) it is, last, 150 mesh sieves excessively by the pulverizing medicinal materials for weighing, is well mixed;
(3), by mixed powder water general for ball, medicine as of the present invention.
The present invention drug administration method be:Daily 2 times, 9 grams every time, warm water delivery service.It is within 3 months 1 course for the treatment of.
To show therapeutic effect of the medicine of the present invention to coronary heart disease, the present inventor is to 200 case clinical observations, wherein man
Property 150 people, 50 people of women, 30 years old age -- 75 years old, course of disease 2--15, by take the present invention medicine, general medication 1---
3 courses for the treatment of, 185 people are cured, and up to 92%, effectively, efficient be 100% to 200 people to cure rate.
Data and method conclusion
1 physical data
1.1 case histories are originated 200, wherein the male sex 108, women 92,40~70 years old age, average 57.6 years old.The course of disease half
Individual month to 10 years, average 7.8 years.
1.2 case selection
1.2.1 diagnostic criteria Western medicine diagnostic criteria is worked out using angiocardiology branch of Chinese Medical Association《The instability mode heart is twisted
The diagnosis and treatment of pain》.Tcm diagnosis standard reference《The clinical research of the traditional Chinese medical science Drugs in Therapy obstruction of qi in the chest (coronary disease and angina pectoris) is instructed
Principle》, tcm syndrome differentiation and typing category is because of qi deficiency to blood stasis.Classical symptom:Uncomfortable in chest, pectoralgia, it is shortness of breath, weak.
1.2.2 inclusive criteria:1. meet doctor trained in Western medicine unstable angina pectoris (excluding infarct angina pectoris, ariant angina)
Diagnostic criteria;2. meet disease of tcm diagnostic criteria;3. Electrocardioscopy has obvious myocardial ischemia evidence;4. age 40-70 year.
1.2.3 exclusion standard:Western medicine diagnostic criteria and differential diagnosis in tcm standard person are not met;When being diagnosed as coronary heart disease heart infarction
And other heart diseases person;Gestation or women breast-feeding their children.Those who are allergic to this drug;It is associated with angiocarpy, lung, liver, kidney and hematopoiesis system
The severe primary disease patients such as system, mental patient;It is all not meet inclusive criteria, not by regulation medication, it is impossible to judge curative effect or
Data is not congruent to affect the treatment and security judgement person.
2 treatment methods
Control group isosorbide dinitrate 10mg, 3 times/d are oral, and Betaloc 12.5mg, 2 times/d are oral, aspirin 100mg, 1 time/d mouth
Clothes, 23 times/d of Tongxinluo medicinal capsule.Treatment group adds medicine of the present invention on the basis of Western medicine, and 5 every time, 3 times a day, takes altogether
With 6 weeks.Two groups of case angina pectoris attackses during observation and treatment are difficult to spontaneous remission person and give buccal monobel.
3 observation indexs
3.1 curative effect determinate standard
3.1.1 recovery from illness:Symptom disappears, and monobel is disabled, and the electrocardiogram ST-T changes recover normal;3.1.2 it is effective:Symptom is bright
Aobvious to mitigate, monobel significantly reduces use, and the electrocardiogram ST-T changes are obviously improved;3.1.3 effectively:Symptom mitigation, nitric acid
Glycerine is reduced and is used, and the electrocardiogram ST-T changes improve;3.1.4 it is invalid:Symptom is not improved, and monobel is without reduction, electrocardio
Figure ST-T changes without improvement.
3.2 health giving quality observation indexs
3.2.1 pectoralgia, uncomfortable in chest, 3.2.2 shortness of breath and fatigue, 3.2.3, the number of times of angina pectoris attacks, duration and monobel are used
Amount, the Electrocardiographic changes of 3.2.4.
4 results
Clinical efficacy after 4.1 treatments:It is shown in Table 1
Clinical efficacy after the treatment of table 1(%)
Number of cases | Recovery from illness | It is effective | Effectively | It is invalid | Total effective rate % |
200 | 50 | 68 | 80 | 2 | 98 |
Cardinal symptom change before and after 4.2 treatments:It is shown in Table 2
4.3 bad reactions without.
Claims (1)
1. a kind of Chinese medicine for treating coronary heart disease, it is characterised in that it is to be prepared from the following raw materials in parts by weight:Tinosporae 2-3
Part, pilose antler 2-3 parts, hawksbill turtle 3-5 parts, dried rhizome of rehmannia 15-20 parts, walnut kernel 12-18 parts, seed of Chinese dodder 10-20 parts, semen litchi 10-20 parts,
Rhodiola root 10-20 parts, RADIX POLYGONI MULTIFLORI PREPARATA 10-20 parts, bighead atractylodes rhizome 10-20 parts, radix achyranthis bidentatae 10-20 parts, ginkgo nut 10-20 parts, mulberry fruit 10-20
Part, date 12-25, chrysanthemum 15-20 parts, safflower 6-9 parts, Morinda officinalis 12-17 parts, raspberry 10-20 parts, 10 15 parts of Radix Glycyrrhizae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611171198.5A CN106511596A (en) | 2016-12-17 | 2016-12-17 | Traditional Chinese medicine for treating coronary heart disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611171198.5A CN106511596A (en) | 2016-12-17 | 2016-12-17 | Traditional Chinese medicine for treating coronary heart disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106511596A true CN106511596A (en) | 2017-03-22 |
Family
ID=58340939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611171198.5A Pending CN106511596A (en) | 2016-12-17 | 2016-12-17 | Traditional Chinese medicine for treating coronary heart disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106511596A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105420039A (en) * | 2015-11-13 | 2016-03-23 | 河南劲阳春酒业有限公司 | Life-maintaining and health-care medicinal liquor |
-
2016
- 2016-12-17 CN CN201611171198.5A patent/CN106511596A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105420039A (en) * | 2015-11-13 | 2016-03-23 | 河南劲阳春酒业有限公司 | Life-maintaining and health-care medicinal liquor |
Non-Patent Citations (1)
Title |
---|
常娟: "《一用就灵 经络通养生手册》", 30 November 2014, 金盾出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101670060A (en) | Traditional Chinese medicine composition for treating such diseases as hepatic stagnation, chest stuffiness and distension and preparation method | |
CN105663607A (en) | Traditional Chinese medicine composition as well as preparation method and application thereof | |
CN103083556A (en) | Traditional Chinese medicine for treating cervical spondylosis | |
CN103830482B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of apoplexy | |
CN107551061B (en) | Capsule for invigorating qi and blood and restoring yang | |
CN100544761C (en) | A kind of medicine for the treatment of coronary heart disease | |
CN101623387B (en) | Pill for treating traumatic injury, new and old fracture and lumbar muscle strain | |
CN101284093B (en) | Chinese herb medicine for treating coronary heart disease | |
CN102526245A (en) | Pill | |
CN102600251B (en) | Rheumatism-rehabilitating traditional Chinese formulation | |
CN106511596A (en) | Traditional Chinese medicine for treating coronary heart disease | |
CN101757329B (en) | Traditional Chinese medicine thrombolysis capsule for treating cerebral thrombosis | |
CN108785421B (en) | A Chinese medicinal composition for treating fracture and its preparation method | |
CN114272329B (en) | Traditional Chinese medicine composition for treating liver and kidney deficiency type cervical spondylosis, preparation and application | |
CN103877216B (en) | One treats myocarditic Chinese drugs agentia and preparation method | |
CN104127620B (en) | A kind of Chinese medicine preparation for treating caput femoris necrosis | |
CN100406035C (en) | Chinese medicine preparation for treating protrasion of lumbar intervertebral disc | |
CN104758888A (en) | Traditional Chinese medicine composition for treating diabetes | |
CN104758346A (en) | Medicine for treating migraine, as well as preparation method and preparation of medicine | |
CN103110719B (en) | Traditional Chinese medicine wine for treating kidney deficiency and essence depletion type osteoporosis | |
CN104524090A (en) | Traditional Chinese medicine preparation for treating sequelae of head injury | |
CN104096112A (en) | Traditional Chinese medicine composition for treating angina pectoris | |
CN101564476B (en) | Chinese medicament for treating coronary heart disease | |
CN104069205A (en) | Traditional Chinese medicine preparation for treating Ankylosing spondylitis | |
CN112755150A (en) | A Chinese medicinal composition for treating heart diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170322 |
|
RJ01 | Rejection of invention patent application after publication |